Analystreport

Xeris Biopharma (NASDAQ:XERS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report